TrialDiabetes, metabolic syndrome and obesity : targets and therapy2026

Polyethylene Glycol Loxenatide Selectively Reduces Adiposity While Preserving Lean Body Mass in Type 2 Diabetes: A 12-Week Clinical Study.

Rong Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.